• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE Back to Search Results
Model Number ESS305
Device Problems Difficult to Remove (1528); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Device Embedded In Tissue or Plaque (3165)
Event Type  Injury  
Event Description
This spontaneous case was reported by a lawyer and describes the occurrence of embedded device ('essure coil intact adherent and implanted into left wall of left cornua of uterus') in an adult female patient who had essure inserted for female sterilisation.The occurrence of additional non-serious events is detailed below.On (b)(6) 2011, the patient had essure inserted.On an unknown date, the patient experienced embedded device (seriousness criteria medically significant and intervention required), pelvic pain ("pelvic pain ") and complication of device removal ("one essure coil still in the proximal tube and cornua area of the uterus on the patient's left side").The patient was treated with surgery (laparoscopic bilateral salpingectomy, essure removal).Essure was removed on (b)(6) 2019.At the time of the report, the embedded device, pelvic pain and complication of device removal outcome was unknown.The reporter considered complication of device removal, embedded device and pelvic pain to be related to essure.The reporter commented: more than one essure related surgery: yes date of essure related surgery: (b)(6) 2019 patient had laparoscopic bilateral salpingectomy done on (b)(6) 2019.At the time of the procedure, it was felt that she had complete removal of the essure device bilaterally, however, she continued to have left-sided pelvic pain and further investigation was performed and imaging revealed the presence of the essure coil still in the proximal tube and cornua area of the uterus on the patient's left side.Quality-safety evaluation of ptc: no defect could be confirmed by the manufacturer.All product batches have met the specifications regarding labeling, material, and process controls at time of release.Trend analyses of complaints are reviewed regularly, no signal was observed with regard to the reported complaint reason.The risk management file was reviewed and an update was not deemed required.A technical investigation of the complaint sample and batch record review could not be conducted, as no sample or batch number were available.Based on the available information, a review of our complaint records and other relevant data was conducted; any new and reportable information that becomes available from our investigation will be provided in a supplementary report.
 
Manufacturer Narrative
This spontaneous case was reported by a lawyer and describes the occurrence of embedded device ('essure coil intact adherent and implanted into left wall of left cornua of uterus') in an adult female patient who had essure inserted for female sterilisation.The occurrence of additional non-serious events is detailed below.On (b)(6) 2011, the patient had essure inserted.On an unknown date, the patient experienced embedded device (seriousness criteria medically significant and intervention required), pelvic pain ("pelvic pain ") and complication of device removal ("one essure coil still in the proximal tube and cornua area of the uterus on the patient's left side").The patient was treated with surgery (laparoscopic bilateral salpingectomy, essure removal).Essure was removed on (b)(6) 2019.At the time of the report, the embedded device, pelvic pain and complication of device removal outcome was unknown.The reporter considered complication of device removal, embedded device and pelvic pain to be related to essure.The reporter commented: more than one essure related surgery: yes date of essure related surgery: (b)(6) 2019 patient had laparoscopic bilateral salpingectomy done on (b)(6) 2019.At the time of the procedure, it was felt that she had complete removal of the essure device bilaterally, however, she continued to have left-sided pelvic pain and further investigation was performed and imaging revealed the presence of the essure coil still in the proximal tube and cornua area of the uterus on the patient's left side.Quality-safety evaluation of ptc: no defect could be confirmed by the manufacturer.All product batches have met the specifications regarding labeling, material, and process controls at time of release.Trend analyses of complaints are reviewed regularly, no signal was observed with regard to the reported complaint reason.The risk management file was reviewed and an update was not deemed required.A technical investigation of the complaint sample and batch record review could not be conducted, as no sample or batch number were available.Most recent follow-up information incorporated above includes: on 14-jul-2021: quality safety evaluation of ptc.Based on the available information, a review of our complaint records and other relevant data was conducted; any new and reportable information that becomes available from our investigation will be provided in a supplementary report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESSURE
Type of Device
TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE
Manufacturer (Section D)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM  13353
MDR Report Key12141973
MDR Text Key260687831
Report Number2951250-2021-02822
Device Sequence Number1
Product Code HHS
UDI-Device Identifier10888853003051
UDI-Public(01)10888853003051
Combination Product (y/n)N
PMA/PMN Number
P020014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,other
Type of Report Initial,Followup
Report Date 07/14/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberESS305
Initial Date Manufacturer Received 08/18/2020
Initial Date FDA Received07/09/2021
Supplement Dates Manufacturer Received07/14/2021
Supplement Dates FDA Received07/14/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-